Streetbeat News

Regulatory

NRSN

NeuroSense Therapeutics shares rise as the company seeks early commercialization approval for PrimeC in ALS under Health Canada's policy.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:07 pm

GAN

GAN Limited has received approval from the Nevada Gaming Commission for its merger with a subsidiary of SEGA SAMMY CREATION INC. The merger is expected to close in late 2024 or early 2025, subject to additional approvals. Upon completion, GAN will be delisted from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:05 pm

NRSN

NeuroSense Therapeutics is seeking early commercialization approval for its drug PrimeC, aimed at treating ALS, under Health Canada's Notice of Compliance with Conditions policy.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:04 pm

DD

DuPont has filed a complaint with the International Trade Commission against Xiamen Dangsheng New Materials and Jiangsu Qingyun New Materials to block the importation of products infringing on its Tyvek brand intellectual property.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:03 pm

SPY

USO

VGK

Russian Deputy PM Novak stated it's too early to determine if the global market can handle more OPEC+ oil in December. No changes to the OPEC+ deal are being discussed, and the format for the Dec. 1 summit will be decided later.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:01 pm

MORT

REZ

A sharp increase in mortgage rates has led to a significant drop in U.S. mortgage applications, as the market reacts to a strong jobs report and rising Treasury yields. Mortgage-linked stocks, including the VanEck Mortgage REIT Income ETF (MORT) and iShares Residential and Multisector Real Estate ETF (REZ), have declined as a result.

Portfolio Pulse from Piero Cingari

October 09, 2024 | 12:59 pm

CI

CNC

CVS

HUM

UNH

The Biden-Harris Administration has proposed a Medicare $2 Drug List Model aimed at reducing prescription costs. The Centers for Medicare & Medicaid Services (CMS) is seeking feedback on a sample drug list and plans to start voluntary participation for Part D sponsors as early as January 2027. The model will include drugs for common conditions and will be updated periodically based on new generics, clinical indications, and pricing trends.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:57 pm

HAIL

HMC

Honda Motor Company (NYSE:HMC) is recalling 1.7 million vehicles due to a defect in the steering gearbox, causing increased friction and potential crash risks. This follows previous recalls for airbag and fire risks. HMC shares are down 1.72% premarket.

Portfolio Pulse from Lekha Gupta

October 09, 2024 | 12:55 pm

CANF

Can-Fite Biopharma's shares rose following the FDA's orphan drug designation for its drug namodenoson, aimed at treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:40 pm

PLL

Piedmont Lithium's shares rose following the announcement that the Ghana Minerals Commission granted a mine operating permit for the Ewoyaa project, a joint venture.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:38 pm